Evolution of renal interstitial inflammation and NF-κB activation in spontaneously hypertensive rats

被引:91
|
作者
Rodríguez-Iturbe, B
Quiroz, Y
Ferrebuz, A
Parra, G
Vaziri, ND
机构
[1] Univ Zulia, Fundacite Zulia, Inst Invest Biomed, Hosp Univ Maracaibo,Renal Serv, Maracaibo 4011, Venezuela
[2] Univ Calif Irvine, Dept Med Physiol & Biophys, Div Nephrol & Hypertens, Irvine, CA USA
关键词
spontaneously hypertensive rats; prehypertensive; hypertension; lymphocytes; macrophages; NF-kappa B;
D O I
10.1159/000082313
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Lymphocytes and macrophages infiltrate the kidney of spontaneously hypertensive rats (SHR) and interventions leading to their reduction are associated with improvement of the hypertension. The present studies examined the evolution of the interstitial inflammation in the natural course of the SHR to gain insight on the potential role of interstitial immune cell accumulation in the development of hypertension. We studied SHR and control WKY rats at 3 weeks (SHR-3wk group, n = 11 and WKY-3wk group, n = 10), 11 weeks (SHR-11wk group, n = 5 and WKY-11wk group, n = 5) and 24 weeks (SHR-24wk group, n = 10 and WKY-24wk group, n = 10). The SHR-3wk group was normotensive and older SHR developed hypertension that was severe in the SHR-24wk group. Tubulointerstitial accumulation of lymphocytes, macrophages, angiotensin II-positive cells, cells expressing the p65 DNA-binding subunit of NF-kappaB and activation of NFIB in the kidney were all significantly increased ( p < 0.01) in the prehypertensive SHR-3wk group and augmented progressively, with the highest values in the SHR-24wk group. The SHR-24wk group showed increased ( p < 0.001) helper (CD4) T cell infiltration and a high CD4/CD8 ratio. These findings are consistent with the possibility that activation of NF-kappaB and renal interstitial infiltration of immune cells may be part of the pathophysiologic process that drives hypertension in the SHR. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:587 / 594
页数:8
相关论文
共 50 条
  • [21] NF-κB activation in melanoma
    Ueda, Y
    Richmond, A
    PIGMENT CELL RESEARCH, 2006, 19 (02): : 112 - 124
  • [22] NF-κB activation in sarcoidosis
    Drent, M
    van den Berg, R
    Haenen, GRMM
    van den Berg, H
    Wouters, EFM
    Bast, A
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2001, 18 (01) : 50 - 56
  • [23] NF-κB, inflammation and pancreatic carcinogenesis:: NF-κB as a chemoprevention target (Review)
    Zhang, Zhiquan
    Rigas, Basil
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 29 (01) : 185 - 192
  • [24] Folate Reverses NF-κB p65/Rela/IL-6 Level Induced by Hyperhomocysteinemia in Spontaneously Hypertensive Rats
    Zhang, Lihua
    Li, Zhongliang
    Xing, Changcheng
    Gao, Ning
    Xu, Rui
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [25] Renal vascular reactivity to P2-purinoceptor activation in spontaneously hypertensive rats
    Fernández, O
    Wangensteen, R
    Osuna, A
    Vargas, F
    PHARMACOLOGY, 2000, 60 (01) : 47 - 50
  • [26] NF-κB activation in renal tubular epithelial cells by oxalate stimulation
    Tozawa, Keiichi
    Yasui, Takahiro
    Okada, Atsushi
    Hirose, Masahito
    Hamamoto, Shuzo
    Itoh, Yasunori
    Kohri, Kenjiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2008, 15 (10) : 924 - 928
  • [27] Linalool inhibits cigarette smoke-induced lung inflammation by inhibiting NF-κB activation
    Ma, Jianqun
    Xu, Hai
    Wu, Jun
    Qu, Changfa
    Sun, Fenglin
    Xu, Shidong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 29 (02) : 708 - 713
  • [28] NF-κB signaling in inflammation and cancer
    Zhang, Tao
    Ma, Chao
    Zhang, Zhiqiang
    Zhang, Huiyuan
    Hu, Hongbo
    MEDCOMM, 2021, 2 (04): : 618 - 653
  • [29] NF-κB and inflammation in genetic disease
    Sebban, Helene
    Courtois, Gilles
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (09) : 1153 - 1160
  • [30] NF-κB: At the Borders of Autoimmunity and Inflammation
    Barnabei, Laura
    Laplantine, Emmanuel
    Mbongo, William
    Rieux-Laucat, Frederic
    Weil, Robert
    FRONTIERS IN IMMUNOLOGY, 2021, 12